Neuroscience and Pain Research
-
Researchers identify new gene linked to Meniere’s disease
Posted on:
In a crucial step towards a better understanding of Meniere’s disease, researchers at the Kolling Institute and the University of Sydney have discovered a gene mutation which could greatly inform future treatment of the disease. Meniere’s is a rare inner ear disease associated with sensorineural hearing loss, vertigo and debilitating tinnitus. There is currently no
-
Groundbreaking work in geriatric pharmacology
Posted on:
For the past 20 years, Professor Sarah Hilmer has dedicated her career to optimising medicine use for older people and has achieved recognition as a national and world leader in geriatric pharmacology. Not only has the Royal North Shore Hospital clinical pharmacologist and geriatrician set about improving medication practices for older people, but she has
-
Top pain specialist and researcher receives Australia Day gong
Posted on:
Internationally respected clinical academic Professor Paul Glare has been named a Member of the Order of Australia for his significant service to medicine in the fields of pain management and palliative care. Professor Glare is a specialist physician in pain medicine and senior researcher with the Kolling Institute. He is the Director of the Michael
-
Next generation of researchers streamlining complex medication choices
Posted on:
Two emerging leaders within the Kolling Institute’s Ageing and Pharmacology Lab are gaining attention for their impressive work to improve the quality use of medications. Dr Nashwa Masnoon and Dr Kenji Fujita have received prestigious awards at the annual meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). Nashwa, who is
-
Clinical trials informed by patient care
Posted on:
The Kolling Institute’s Professor Sue Kurrle and her team at the Rehabilitation and Aged Care Network at Hornsby Ku-ring-gai Hospital have been running clinical trials for 25 years, looking at dementia, frailty, and falls to name just some areas. “We do trials as it keeps you cutting edge and they are really important for our
-
Kolling Research Symposium 2024
Posted on:
We would like to thank everyone involved in the 2024 Kolling Institute Symposium. During the event, a diverse collection of researchers detailed the latest progress with their ground-breaking work into kidney and heart disease treatments, bone and muscle conditions, rare cancers, and neurological challenges. There was a focus too on the innovative work to develop
-
Kolling NEWS
Posted on:
Our Kolling Institute newsletter brings together a collection of profiles on our impressive researchers. Flip through our flipping book to discover more about our leading research into kidney disease, rare cancers and the use of supplements for osteoarthritis. There’s a focus too on the first steps towards gene therapy for Meniere’s disease, the latest research into treatments for
-
Culturally relevant pain solutions
Posted on:
After training as a musculoskeletal physiotherapist in India, the Kolling Institute’s Dr Saurab Sharma returned to Nepal to treat patients with musculoskeletal pain conditions but quickly found that Western practices to assess and treat pain didn’t translate well to his community. One issue was the internationally-recognised numeric pain rating scale, where zero indicates no pain
-
New collaboration to drive world leading research into osteoarthritis treatment
Posted on:
An innovative partnership with industry will see our researchers at the Kolling Institute develop evidence-based strategies to improve osteoarthritis management in Australia and globally. Consumer healthcare company Haleon is sponsoring a five-year fellowship to investigate the role of supplements in managing osteoarthritis and digital health technologies to improve mobility. Osteoarthritis is a leading cause of
-
Collaboration driving results
Posted on:
The Northern Sydney (Arabanoo) Precinct hosted its annual showcase at the Kolling, highlighting the innovative research between the Northern Sydney Local Health District and the University of Sydney. Launched in 2022 by Academic Directors Professors James Elliott, Robyn Gallagher and Margaret Schnitzler, the showcase focused on the joint research tackling complex healthcare challenges. Eight speakers
Copyright © 2026 Kolling Institute
All rights reserved